Tuberculosis treatment success rate in Libya
Libya: Tuberculosis treatment success rate was 57.0% in 2023. ▼ Falling
Tuberculosis treatment success rate in Libya, 2002–2023
Source: Global Tuberculosis Report, World Health Organization (WHO). Measured in % of new cases.
Analysis
In 2023, tuberculosis treatment success rate in Libya stood at 57.0%. That is the lowest value across all 21 years on record.
That represents a change of down 5.0% on the previous year and down 3.4% over ten years.
Over the whole period, tuberculosis treatment success rate in Libya peaked at 77.0% in 2006 and was at its lowest, 57.0%, in 2014.
Libya ranks 184th of 203 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 21 years of available data.
Tuberculosis treatment success rate in Libya, year by year
| Year | % of new cases | Change |
|---|---|---|
| 2002 | 61.0% | — |
| 2003 | 62.0% | +1.6% |
| 2004 | 64.0% | +3.2% |
| 2005 | 69.0% | +7.8% |
| 2006 | 77.0% | +11.6% |
| 2007 | 64.0% | -16.9% |
| 2008 | 70.0% | +9.4% |
| 2010 | 61.0% | -12.9% |
| 2011 | 59.0% | -3.3% |
| 2012 | 60.0% | +1.7% |
| 2013 | 59.0% | -1.7% |
| 2014 | 57.0% | -3.4% |
| 2015 | 61.0% | +7.0% |
| 2016 | 59.0% | -3.3% |
| 2017 | 59.0% | +0.0% |
| 2018 | 69.0% | +16.9% |
| 2019 | 70.0% | +1.4% |
| 2020 | 69.0% | -1.4% |
| 2021 | 62.0% | -10.1% |
| 2022 | 60.0% | -3.2% |
| 2023 | 57.0% | -5.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 66.7% | 61.0% | 77.0% | 7 |
| 2010s | 61.4% | 57.0% | 70.0% | 10 |
| 2020s | 62.0% | 57.0% | 69.0% | 4 |
Countries ranked near Libya
- 181 Fiji 60.0% compare
- 181 Saint Vincent and the Grenadines 60.0% compare
- 183 Switzerland 58.0% compare
- 185 Cape Verde 55.0% compare
- 186 Poland 54.0% compare
- 187 Argentina 52.0% compare
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Population ages 50-54, male, annual growth rate 3.28 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0318 units per person (2025)
- Population ages 55-59, female, annual growth rate 6.5 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0238 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Libya?
- Tuberculosis treatment success rate in Libya was 57.0% in 2023, according to Global Tuberculosis Report, World Health Organization (WHO).
- What is the highest tuberculosis treatment success rate recorded in Libya?
- The highest recorded value was 77.0% in 2006.
- What is the lowest tuberculosis treatment success rate recorded in Libya?
- The lowest recorded value was 57.0% in 2014.
- How does Libya rank for tuberculosis treatment success rate?
- Libya ranks 184th out of 203 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Libya?
- Over the last ten years it is down 3.4%. The long-run trend across the full record is falling.
- Where does this Libya data come from?
- The figures come from Global Tuberculosis Report, World Health Organization (WHO), published as part of Tuberculosis treatment success rate (% of new cases). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).